VitalHub Corp. Recognized Among Top Performers in the 2024 TSX30 Ranking
VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) has been recognized in the 2024 TSX30™, ranking 26th among the top 30 performing stocks on the Toronto Stock Exchange over the past three years. The company achieved a 136% three-year dividend-adjusted share price performance and a 231% increase in market capitalization. CEO Dan Matlow attributed this success to VitalHub's commitment to innovation, operational excellence, and strategic acquisitions, including the planned addition of MedCurrent
The TSX30™ program, established in 2019, highlights the strength of Canada's public markets and its role in driving economic growth. VitalHub's inclusion underscores its successful growth strategy, disciplined cash management, and vision for enhancing healthcare delivery worldwide. The company remains focused on sustainable growth and delivering value to stakeholders in the healthcare technology sector.
VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) è stata riconosciuta nel TSX30™ 2024, classificandosi al 26° posto tra le 30 azioni con le migliori performance sulla Borsa di Toronto negli ultimi tre anni. L'azienda ha registrato una performance del prezzo delle azioni aggiustata per i dividendi del 136% in tre anni e un incremento del 231% della capitalizzazione di mercato. Il CEO Dan Matlow ha attribuito questo successo all'impegno di VitalHub per l'innovazione, l'eccellenza operativa e le acquisizioni strategiche, inclusa l'aggiunta pianificata di MedCurrent.
Il programma TSX30™, istituito nel 2019, evidenzia la forza dei mercati pubblici canadesi e il loro ruolo nel favorire la crescita economica. L'inclusione di VitalHub sottolinea la sua strategia di crescita di successo, la gestione disciplinata del cash flow e la visione per migliorare la fornitura di servizi sanitari a livello globale. L'azienda rimane concentrata su una crescita sostenibile e sulla creazione di valore per gli stakeholder nel settore della tecnologia sanitaria.
VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) ha sido reconocida en el TSX30™ 2024, ocupando el puesto 26 entre las 30 acciones de mejor rendimiento en la Bolsa de Toronto en los últimos tres años. La compañía logró un rendimiento del precio de las acciones ajustado por dividendos del 136% en tres años y un incremento del 231% en la capitalización de mercado. El CEO Dan Matlow atribuyó este éxito al compromiso de VitalHub con la innovación, la excelencia operativa y las adquisiciones estratégicas, incluida la incorporación planificada de MedCurrent.
El programa TSX30™, establecido en 2019, destaca la fortaleza de los mercados públicos de Canadá y su papel en el fomento del crecimiento económico. La inclusión de VitalHub subraya su exitosa estrategia de crecimiento, la gestión disciplinada del efectivo y la visión para mejorar la entrega de atención médica a nivel mundial. La empresa sigue centrada en un crecimiento sostenible y en ofrecer valor a los interesados en el sector de tecnología de la salud.
VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF)는 2024 TSX30™에서 토론토 증권 거래소에서 지난 3년 동안 최고의 성과를 보인 30개 주식 중 26위로 선정되었습니다. 이 회사는 3년간 배당금을 반영한 주가 성과 136%와 시장 가치 231% 증가를 달성했습니다. CEO Dan Matlow는 VitalHub의 혁신, 운영 우수성 및 전략적 인수에 대한 헌신, 특히 MedCurrent의 계획된 추가가 이러한 성공에 기여했다고 언급했습니다.
2019년에 설립된 TSX30™ 프로그램은 캐나다 공공 시장의 강점을 강조하고 경제 성장을 촉진하는 역할을 하고 있습니다. VitalHub의 등장은 성공적인 성장 전략, 규 disciplined lated cash management, 및 전 세계의 의료 서비스를 향상시키려는 비전을 강조합니다. 이 회사는 지속 가능한 성장과 헬스케어 기술 분야의 이해관계자에게 가치를 제공하는 데 주력하고 있습니다.
VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) a été reconnue dans le TSX30™ 2024, se classant au 26ème rang parmi les 30 actions les mieux performantes de la Bourse de Toronto au cours des trois dernières années. L'entreprise a réalisé une performance du prix des actions ajustée en fonction des dividendes de 136% sur trois ans et une augmentation de 231% de la capitalisation boursière. Le PDG Dan Matlow a attribué ce succès à l'engagement de VitalHub en faveur de l'innovation, de l'excellence opérationnelle et des acquisitions stratégiques, y compris l'ajout prévu de MedCurrent.
Le programme TSX30™, lancé en 2019, met en lumière la force des marchés publics canadiens et leur rôle dans la promotion de la croissance économique. L'inclusion de VitalHub souligne sa stratégie de croissance réussie, sa gestion disciplinée des liquidités et sa vision pour améliorer la livraison des soins de santé à l'échelle mondiale. L'entreprise reste concentrée sur une croissance durable et sur la création de valeur pour les parties prenantes dans le secteur de la technologie de la santé.
VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) wurde im TSX30™ 2024 anerkannt und belegte den 26. Platz unter den 30 am besten abschneidenden Aktien an der Toronto Stock Exchange in den letzten drei Jahren. Das Unternehmen erzielte eine 136%ige Dividenden-adjustierte Aktienkursentwicklung in drei Jahren und einen 231%igen Anstieg der Marktkapitalisierung. CEO Dan Matlow führte diesen Erfolg auf das Engagement von VitalHub für Innovation, operative Exzellenz und strategische Akquisitionen zurück, einschließlich der geplanten Hinzufügung von MedCurrent.
Das TSX30™-Programm, das 2019 ins Leben gerufen wurde, hebt die Stärke der öffentlichen Märkte Kanadas und deren Rolle bei der Förderung des Wirtschaftswachstums hervor. Die Aufnahme von VitalHub unterstreicht ihre erfolgreiche Wachstumsstrategie, disziplinierte Cash-Management und die Vision zur Verbesserung der Gesundheitsversorgung weltweit. Das Unternehmen bleibt auf nachhaltiges Wachstum und die Schaffung von Wert für die Stakeholder im Bereich der Gesundheitstechnologien fokussiert.
- Ranked 26th in the 2024 TSX30™ list of top-performing stocks
- 136% three-year dividend-adjusted share price performance
- 231% increase in market capitalization over three years
- Successful implementation of strategic acquisitions strategy
- Planned acquisition of MedCurrent to strengthen market position
- None.
Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is proud to announce its inclusion in the 2024 TSX30™, the Toronto Stock Exchange's prestigious ranking of the top 30 performing stocks over the past three years. VitalHub has achieved the 26th position on this esteemed list, showcasing a remarkable
"We are honored to be recognized as one of the top performers on the Toronto Stock Exchange," said Dan Matlow, CEO of VitalHub. "This accolade reflects our relentless commitment to innovation and operational excellence. Our initiatives, which have included a number of strategic and complimentary acquisitions, like the planned addition of MedCurrent Corporation, have not only propelled our growth but also strengthened our market position. This recognition is a testament to our team's hard work and the trust our customers and investors place in us."
The TSX30™ program, established in 2019, recognizes TSX-listed companies who have demonstrated excellence in growth, highlights the overall strength of Canada's diverse and ever-evolving public markets, and the efficacy of this powerful ecosystem in driving growth for issuers, investors, and the overall economy. VitalHub's inclusion in this ranking underscores the success of its focused growth strategy, both organic and through strategic acquisitions. The Company's robust performance is supported by disciplined cash management and a clear vision for the future, aiming to enhance healthcare delivery worldwide.
"As we celebrate this achievement, we remain dedicated to driving sustainable growth and continuing to deliver value to our stakeholders," added Matlow. "Looking ahead, we are excited about our future prospects and our ongoing efforts to lead the transformation in healthcare technology."
VitalHub invites shareholders and potential investors to learn more about our strategic direction and operational achievements that have contributed to our TSX30™ ranking. For further details, please visit our website at https://www.vitalhub.com/.
ABOUT VITALHUB
Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes.
VitalHub is a leading software company dedicated to empowering Health and Human Services providers. Our clients include hospitals, regional health authorities, mental health and addictions services providers for children and adults, long-term care facilities, home health agencies, correctional services, and community and social services providers.
VitalHub's comprehensive suite of SaaS solutions include:
- Electronic Health Record (EHR), Case Management, Care Coordination, and Optimization
- Patient Flow, Operational Visibility, and Patient Journey Optimization
- Workforce Automation & Compliance
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently VitalHub serves more than 1,000 clients across Canada, USA, UK, Australia, the Middle East, and Europe.
VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The VitalHub team comprises more than 400 team members globally. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol "VHI" and on the OTC Markets OTCQX Exchange under the symbol "VHIBF".
CONTACT INFORMATION
VitalHub Corp.
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
dan.matlow@vitalhub.com
CAUTIONARY STATEMENT
This news release contains "forward-looking information" within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer's business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer's prospective financial performance or financial position. The forward-looking information in this news release includes reference to disclosure about the terms of the Transaction, about MedCurrent, including its historical revenue and future recurring revenue, and about potential synergies among existing offerings in the issuer's patient flow products as well as the potential for the international application of MedCurrent's product offerings. VitalHub made certain material assumptions, including but not limited to: prevailing market conditions; general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of VitalHub and MedCurrent to execute and achieve its business objectives, to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to: adverse market conditions; the inability of VitalHub and MedCurrent to successfully integrate operations; reliance on key and qualified personnel; and regulatory and other risks associated with the medical and technology industries in general. The foregoing list of material risk factors and assumptions is not exhaustive. VitalHub assumes no obligation to update or revise the forward-looking information in this news release unless it is required to do so under Canadian securities legislation.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222644
FAQ
What ranking did VitalHub Corp. (VHIBF) achieve in the 2024 TSX30™ list?
What was VitalHub's (VHIBF) three-year dividend-adjusted share price performance?
How much did VitalHub's (VHIBF) market capitalization increase over the past three years?
What strategic acquisition is VitalHub (VHIBF) planning to strengthen its market position?
When was the TSX30™ program established?
